Metalloproteinases and osteoblast EGFR signaling in osteolytic bone metastasis of breast cancer

Cell Cycle

Volumn 8, Issue 23, 2009, Pages 3804-3805

  Lu, Xin ^a   Kang, Yibin ^a,b  

^a PRINCETON UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Bone metastasis; Breast cancer; EGFR; Metalloproteinase; Osteoblast; Osteoclast

Indexed keywords

AMPHIREGULIN; BETACELLULIN; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EPIREGULIN; GEFITINIB; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; NEU DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSFORMING GROWTH FACTOR ALPHA;

BONE METASTASIS; BONE REMODELING; BREAST CANCER; CANCER SURVIVAL; DRUG MECHANISM; HUMAN; MICROENVIRONMENT; OSTEOBLAST; OSTEOLYSIS; SHORT SURVEY;

EID: 74849103295     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.23.10104     Document Type: Short Survey

References (12)

1. Lu X, et al. J Mammary Gland Biol Neoplasia 2007; 12:153-62.
2. Mundy GR. Nat Rev Cancer 2002; 2:584-93.
3. Guise TA, et al. Clin Breast Cancer 2005; 5:46-53.
4. Hynes NE, et al. Nat Rev Cancer 2005; 5:341-54.
5. Normanno N, et al. Front Biosci 2005; 10:2611-7.
6. Albain K, et al. Kluwer Academic Publ 2002; 20.
7. von Minckwitz G, et al. Breast Cancer Res Treat 2005; 89:165-72.
8. Wang K, et al. J Biol Chem 2004; 279:53848-56.
9. Chan S-Y, et al. J Biol Chem 2000; 275:38693-8.
10. Zhu J, et al. J Biol Chem 2007; 282:26656-64.
11. Lu X, et al. Genes Dev 2009; 23:1882-94.
12. Kang Y, et al. Cancer Cell 2003; 3:537-49.